RHÖN-KLINIKUM Aktiengesellschaft (LON:0NQH)
12.90
-0.25 (-1.90%)
At close: Feb 11, 2026
LON:0NQH Revenue
RHÖN-KLINIKUM Aktiengesellschaft had revenue of 498.00M EUR in the quarter ending September 30, 2025, with 7.60% growth. This brings the company's revenue in the last twelve months to 1.95B, up 6.41% year-over-year. In the year 2024, RHÖN-KLINIKUM Aktiengesellschaft had annual revenue of 1.87B with 7.67% growth.
Revenue (ttm)
1.95B EUR
Revenue Growth
+6.41%
P/S Ratio
0.44
Revenue / Employee
102.57K EUR
Employees
19,041
Market Cap
758.06M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.87B | 133.13M | 7.67% |
| Dec 31, 2023 | 1.73B | 73.57M | 4.43% |
| Dec 31, 2022 | 1.66B | 69.95M | 4.40% |
| Dec 31, 2021 | 1.59B | 45.15M | 2.92% |
| Dec 31, 2020 | 1.55B | 65.12M | 4.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Advanced Medical Solutions Group | 220.30M |
| Oxford Nanopore Technologies | 204.69M |